Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Neoplasia (New York, N.Y.)|November 3, 2021
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosisDaniela Berger, Karin Bauer, Christoph Kornauth, et al.
Annals of the Rheumatic Diseases|July 21, 2021
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunityDaniel Mrak, Selma Tobudic, Maximilian Koblischke, et al.
Haematologica|April 24, 2025
Changes in cardiac parameters during venetoclax treatmentRoman Brock, Edit Porpaczy, Patrick Caron, et al.
Annals of Neurology|January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic PatientsBarbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trialMichael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Cancer Medicine|March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignanciesAlexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.
Annals of the Rheumatic Diseases|September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controlsFelix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Blood|April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromesMaria Sirenko, Elsa Bernard, Maria Creignou, et al.
Pageof 4